2024 latest report on hepatitis B virus epidemiology in China: current status, changing trajectory, and challenges.

ABSTRACT: Hepatitis B virus (HBV) infection is a significant global public health concern, particularly in China, which accounts for one-third of the world's chronic HBV cases. Over the past three decades, China has made substantial progress in controlling HBV infection. Currently, the vaccination rate of the three-dose hepatitis B vaccine in China has risen to 99.6%, and the coverage of timely birth dose has reached 95.6%, significantly exceeding the global average level. The recent edition of chronic hepatitis B (CHB) prevention and treatment guideline has further expanded the treatment population to allow 94% of CHB patients meet the treatment criteria. With the complete immunization for newborns, in combination with antiviral treatment for HBV infected pregnant women, the mother-to-child transmi

SUBMITTER: Yan R 

PROVIDER: S-EPMC11806133 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature